Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Benjamin L. Palleiko currently holds 479,989 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin L. Palleiko has been a net seller of KALV stock. They have purchased $16.3K and sold $4.9M worth of shares.
Benjamin L. Palleiko's most recent insider trade was on May 22, 2026, when they sold 10,926 shares at $26.78 per share.
Benjamin L. Palleiko serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 89 insider transactions totaling $4.9M over their tenure at the company.
Benjamin L. Palleiko holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Benjamin L. Palleiko has shown a selling trading pattern, with $16.3K in total purchases and $4.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Benjamin L. Palleiko was on Jul 9, 2025, when they sold $517.4K worth of KALV shares. This transaction involved 32,979 shares at $15.69 per share.
Benjamin L. Palleiko currently owns 479,989 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Benjamin L. Palleiko's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Benjamin L. Palleiko has 89 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Benjamin L. Palleiko and 40,000+ other insiders.